Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
- PMID: 37807924
- DOI: 10.1161/CIR.0000000000001184
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
Erratum in
-
Correction to: Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.Circulation. 2024 Mar 26;149(13):e1023. doi: 10.1161/CIR.0000000000001241. Epub 2024 Mar 25. Circulation. 2024. PMID: 38527138 No abstract available.
Abstract
Cardiovascular-kidney-metabolic health reflects the interplay among metabolic risk factors, chronic kidney disease, and the cardiovascular system and has profound impacts on morbidity and mortality. There are multisystem consequences of poor cardiovascular-kidney-metabolic health, with the most significant clinical impact being the high associated incidence of cardiovascular disease events and cardiovascular mortality. There is a high prevalence of poor cardiovascular-kidney-metabolic health in the population, with a disproportionate burden seen among those with adverse social determinants of health. However, there is also a growing number of therapeutic options that favorably affect metabolic risk factors, kidney function, or both that also have cardioprotective effects. To improve cardiovascular-kidney-metabolic health and related outcomes in the population, there is a critical need for (1) more clarity on the definition of cardiovascular-kidney-metabolic syndrome; (2) an approach to cardiovascular-kidney-metabolic staging that promotes prevention across the life course; (3) prediction algorithms that include the exposures and outcomes most relevant to cardiovascular-kidney-metabolic health; and (4) strategies for the prevention and management of cardiovascular disease in relation to cardiovascular-kidney-metabolic health that reflect harmonization across major subspecialty guidelines and emerging scientific evidence. It is also critical to incorporate considerations of social determinants of health into care models for cardiovascular-kidney-metabolic syndrome and to reduce care fragmentation by facilitating approaches for patient-centered interdisciplinary care. This presidential advisory provides guidance on the definition, staging, prediction paradigms, and holistic approaches to care for patients with cardiovascular-kidney-metabolic syndrome and details a multicomponent vision for effectively and equitably enhancing cardiovascular-kidney-metabolic health in the population.
Keywords: AHA Scientific Statements; chronic kidney disease; diabetes; metabolic syndrome; obesity; risk prediction; social determinants of health.
Comment in
-
A united vision for cardiovascular-kidney-metabolic health.Nat Rev Nephrol. 2024 May;20(5):273-274. doi: 10.1038/s41581-024-00812-6. Nat Rev Nephrol. 2024. PMID: 38287135 No abstract available.
Similar articles
-
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association.Circulation. 2023 Nov 14;148(20):1636-1664. doi: 10.1161/CIR.0000000000001186. Epub 2023 Oct 9. Circulation. 2023. PMID: 37807920 Review.
-
Cardiovascular-kidney-metabolic Syndrome: a current and urgent concept.J Bras Nefrol. 2025 Apr-Jun;47(2):e20240277. doi: 10.1590/2175-8239-JBN-2024-0277en. J Bras Nefrol. 2025. PMID: 40393033 Free PMC article.
-
Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association.Circulation. 2023 Dec 12;148(24):1982-2004. doi: 10.1161/CIR.0000000000001191. Epub 2023 Nov 10. Circulation. 2023. PMID: 37947094 Review.
-
Here's What to Know About Cardiovascular-Kidney-Metabolic Syndrome, Newly Defined by the AHA.JAMA. 2023 Dec 5;330(21):2042-2043. doi: 10.1001/jama.2023.22276. JAMA. 2023. PMID: 37938824
-
Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association.Stroke. 2012 Jul;43(7):1998-2027. doi: 10.1161/STR.0b013e31825bcdac. Epub 2012 May 24. Stroke. 2012. PMID: 22627990
Cited by
-
Associations between Diabetes-Specific Medication Regimen Complexity and Cardiometabolic Outcomes among Underserved Non-Hispanic Black Adults Living with Type 2 Diabetes Mellitus.Pharmacy (Basel). 2024 May 26;12(3):83. doi: 10.3390/pharmacy12030083. Pharmacy (Basel). 2024. PMID: 38921959 Free PMC article.
-
High serum copper as a risk factor of all-cause and cause-specific mortality among US adults, NHANES 2011-2014.Front Cardiovasc Med. 2024 Apr 19;11:1340968. doi: 10.3389/fcvm.2024.1340968. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38707892 Free PMC article.
-
Prevalence Rates of Abdominal Obesity, High Waist-to-Height Ratio and Excess Adiposity, and Their Associated Cardio-Kidney-Metabolic Factors: SIMETAP-AO Study.Nutrients. 2024 Nov 19;16(22):3948. doi: 10.3390/nu16223948. Nutrients. 2024. PMID: 39599733 Free PMC article.
-
Assessing the contribution of plastic-associated obesogenic compounds to cardiometabolic diseases.Curr Opin Endocrinol Diabetes Obes. 2024 Apr 1;31(2):98-103. doi: 10.1097/MED.0000000000000852. Epub 2023 Dec 6. Curr Opin Endocrinol Diabetes Obes. 2024. PMID: 38054472 Free PMC article. Review.
-
The relationship between the age of onset of hypertension and chronic kidney disease: a cross-sectional study of the American population.Front Cardiovasc Med. 2024 Dec 12;11:1426953. doi: 10.3389/fcvm.2024.1426953. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39726943 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical